NCCN临床实践指南_止吐(2019.V1)英文版
67页1、Version 1 2019 02 28 19 2019 National Comprehensive Cancer Network NCCN All rights reserved NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines Antiemesis Version 1 2019 February 28 2019 Continue NCCN org NCCN Guidelines for Patients available at www nccn org patients NCCN Guidelines Version 1 2019 Antiemesis Version 1 2019 02 28 19 2019 National Comprehensive Cancer N
2、etwork NCCN All rights reserved NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN NCCN Guidelines Index Table of Contents Discussion David S Ettinger MD Chair The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Michael J Berger PharmD BCOP Vice Chair The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute Jonathan Aston PharmD BCOP Vanderbilt Ingram Cancer Center Sall
3、y Barbour PharmD BCOP CPP Duke Cancer Institute Jason Bergsbaken PharmD BCOP University of Wisconsin Carbone Cancer Center Debra Brandt DO Yale Cancer Center Smilow Cancer Hospital George E Brown RPh MS BCOP Case Comprehensive Cancer Center University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute Jennie R Crews MD Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance Eun Jeong Kim PharmD MS Stanford Cancer Institute Steve Kirkegaard PharmD Huntsman C
4、ancer Institute at the University of Utah Dwight D Kloth PharmD BCOP Fox Chase Cancer Center Kelsey Klute MD Fred 23 382 388 Nakashima K Murakami H Yokoyama K et al A phase II study of palonosetron aprepitant dexamethasone and olanzapine for the prevention of cisplatin based chemotherapy induced nausea and vomiting in patients with thoracic malignancy Jpn J Clin Oncol 2017 47 840 843 AE 6 The following references were removed from the footnotes and are now listed in the Discussion Yanai T Iwasa
5、S Hashimoto H et al A double blind randomized phase II dose finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin based chemotherapy Int J Clin Oncol 2018 23 382 388 Nakashima K Murakami H Yokoyama K et al A phase II study of palonosetron aprepitant dexamethasone and olanzapine for the prevention of cisplatin based chemotherapy induced nausea and vomiting in patients with thoracic malignancy Jpn J Clin Oncol 2017 47 840 843 Added the follo
《NCCN临床实践指南_止吐(2019.V1)英文版》由会员沧海****3分享,可在线阅读,更多相关《NCCN临床实践指南_止吐(2019.V1)英文版》请在金锄头文库上搜索。
洁厕灵企业技术标准范例
发电企业热工设备检修规程
发电企业热控日常点检标准
发电企业汽机(含燃机)技术监督细则
发电企业电气设备保护及安全自动装置投退和定值变更管理标准
继电保护定值变更通知单
继电保护及安全自动装置投退审批表
电气保护定值更改申请单
化工企业粉尘涉爆企业整体安全风险等级评估方法
化工企业安全检查管理规程
电气安全管理规程范例
农业企业绿色食品大棚生菜生产操作规程
农业企业绿色食品桃园管理规程
农业企业绿色食品早春蕹菜生产操作规程
农业企业绿色食品大棚蚕豆促早栽培生产技术操作规程
农业企业绿色食品荠菜种植规程
农业企业绿色食品青椒种植规程
农业企业绿色食品筒篙种植规程
农业企业绿色食品油麦菜种植规程
农业企业绿色食品木耳菜种植规程
2023-05-11 11页
2022-09-05 10页
2022-08-18 10页
2022-08-18 6页
2022-08-18 7页
2022-08-18 3页
2022-08-18 5页
2022-08-18 9页
2022-08-18 7页
2022-08-18 4页